tiprankstipranks
Trending News
More News >
Antengene Corporation Limited (HK:6996)
:6996

Compare Antengene Corporation Limited (6996) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Antengene Corporation Limited
HK$5.27
HK$2.12B
-8.93
329.49%
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.40B
-3.40
-39.57%
SinoMab Bioscience Ltd.
HK$1.39
HK$1.87B
-9.46
34.65%
Immunotech Biopharm Ltd
HK$2.68
HK$1.60B
-6.01
2.82%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6996
Antengene Corporation Limited
3.35
2.61
352.70%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.01
-3.34
-40.00%
HK:3681
SinoMab Bioscience Ltd.
1.36
0.35
34.65%
HK:6978
Immunotech Biopharm Ltd
2.59
0.09
3.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts